ANGPTL3 Targeting Monoclonal Antibodies Lead to Robust Reductions in LDL-C, Triglycerides, ApoB, and Non-HDL-C in Dyslipidemic Patients: A Meta-Analysis of 5 Randomized Controlled Trials

AHA Scientific Sessions 2025 Abstract

The paper

Roger Williams Medical Center · Guthrie Robert Packer Hospital

AHA Scientific Sessions 2025 Abstract · 3 Nov 2025

Presented at AHA Scientific Sessions 2025 · Abstract 4371215

doi.org/10.1161/circ.152.suppl_3.4371215